APA (7th ed.) Citation

Emmanouil Sinakos, Nandita Kachru, Christos Tsoulas, Sushanth Jeyakumar, Nathaniel J Smith, Alon Yehoshua, & Evangelos Cholongitas. (2024). Cost-effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece. Becaris Publishing Limited.

Chicago Style (17th ed.) Citation

Emmanouil Sinakos, Nandita Kachru, Christos Tsoulas, Sushanth Jeyakumar, Nathaniel J Smith, Alon Yehoshua, and Evangelos Cholongitas. Cost-effectiveness of Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Versus Entecavir for Chronic Hepatitis B Patients in Greece. Becaris Publishing Limited, 2024.

MLA (9th ed.) Citation

Emmanouil Sinakos, et al. Cost-effectiveness of Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Versus Entecavir for Chronic Hepatitis B Patients in Greece. Becaris Publishing Limited, 2024.